Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Bioforce Nanosciences Holdings Q3 2026 Results: Net Loss of $342K, Loss Widens

BioForce Nanosciences Holdings, Inc. reported a net loss of $205,410 for the nine months ended September 30, 2026, a significant improvement from the $1,174,153 loss in the prior year period, primarily due to $502,373 in debt forgiveness. On June 18, 2026, the company pivoted its business operations from the vitamin supplement industry to the oil and gas industry.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Profit before tax-0.3-0.1
Net income-0.3-0.1
EPS (diluted, $ a share)$-0.01$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: BFNH. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Bioforce Nanosciences Holdings, Inc.: key numbers

Share price
$6.52Close, Nov 16
Market cap
$248M
Shares outstanding
38.07MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Laboratory Analytical InstrumentsSIC 3826

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Bioforce Nanosciences Holdings, Inc.

All →
11:35 AM ET 8-K
M&A Deal

Bioforce Nanosciences Holdings M&A Deal with CELT eResources, LLC

Bioforce Nanosciences Holdings, Inc. received an assignment of an oil and gas lease covering approximately 40.19 acres in Liberty County, Texas, from CELT eResources, LLC. The transaction, which includes all related wells, equipment, and permits, was approved by the Liberty County Clerk's Office on October 2, 2026. Both the assignor and assignee are controlled by Nexus Capital Investments, Inc.

Counterparty
CELT eResources, LLC

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.